FROM CELLS TO THERAPEUTICS VIVALIS
LIVE

Serial Number

79105465

Owner

VIVALIS

Filing Date

Jul 26, 2011

Add to watchlist:

No watchlists yet
View on USPTO

FROM CELLS TO THERAPEUTICS VIVALIS Trademark

Serial Number: 79105465 • Registration: 4287225

FROM CELLS TO THERAPEUTICS VIVALIS is a trademark filed by VIVALIS on July 26, 2011. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

VIVALIS (4 trademarks)

LIEUDIT LA CORBIÈRE
49450 ROUSSAY , FR

Entity Type: 11

Trademark Details

Filing Date

July 26, 2011

Registration Date

February 12, 2013

Published for Opposition

August 7, 2012

Cancellation Date

July 26, 2021

Goods & Services

Prophylactic and therapeutic medicines, pharmaceutical and veterinary medicines, namely, medical, biological, biotechnological and/or genetic technology preparations and products for medical, pharmaceutical or veterinary use for the treatment of autoimmune diseases, inflammation, cancer, infectious diseases, diseases of the central nervous system, cardiovascular diseases, neurodegenerative and chronic diseases; micro-organisms, cells, cell lines, viruses, nucleotides, plasmids, DNA or RNA sequences, vectors for therapy and diagnosis, all for medical use; molecules and antibodies for medical or pharmaceutical use; biotechnological products for medical or pharmaceutical use, namely, for use in the treatment of autoimmune diseases, inflammation, cancer, infectious diseases, diseases of the central nervous system, cardiovascular diseases, neurodegenerative and chronic diseases; diagnosis products for medical or pharmaceutical use, namely, prophylactic and therapeutic vaccines, none relating to sexual health

Molecules obtained from biotechnologies, proteins, biotechnological products for research and diagnosis; proteins in raw material form for scientific and medical research; micro-organisms, namely, cultures of micro-organisms other than for medical and veterinary use; cells, avian embryonic stem cells, cell lines, viruses, nucleotides, plasmids, DNA or RNA sequences, vectors for research and diagnosis, all these products being not for medical or veterinary purposes; biological preparations for use in cell cultures other than for medical or veterinary purposes; bacteriological preparations for use in cell cultures other than for medical and veterinary use

Scientific services, namely, scientific research; research and development of new products or process for production and/or purification of biological products for third parties; biological research and research in the fields of bacteriology, virology, immunology, biotechnology, genetics, medicine, pharmacology, and scientific research services for medical purposes; scientific research services for pharmaceutical purposes and scientific research services for veterinary purposes; development of technologies and scientific and industrial research to obtain and prepare cells, cell lines, and to produce and/or purify proteins, viruses, human and animal material

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Feb 19, 2022 DENC
DEATH OF INTERNATIONAL REGISTRATION
Feb 19, 2022 DETH
TOTAL INVALIDATION PROCESSED BY THE IB
Jul 17, 2020 INNT
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Jun 16, 2020 INTS
INVALIDATION PROCESSED
Jun 16, 2020 INPC
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
May 13, 2020 INTR
NEW REPRESENTATIVE AT IB RECEIVED
Sep 26, 2019 NREP
CANCELLED SECTION 71
Sep 13, 2019 C71T
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 19, 2018 TCCA
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Feb 12, 2018 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Jun 2, 2013 FINO
FINAL DISPOSITION NOTICE SENT TO IB
May 14, 2013 FICS
FINAL DISPOSITION PROCESSED
May 14, 2013 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
May 12, 2013 FICR
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Apr 19, 2013 LIMN
LIMITATION OF GOODS RECEIVED FROM IB
Apr 6, 2013 LIMG
NEW REPRESENTATIVE AT IB RECEIVED
Mar 2, 2013 NREP
REGISTERED-PRINCIPAL REGISTER
Feb 12, 2013 R.PR
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Dec 21, 2012 ETOP
LIMITATION FROM THE IB EXAMINED AND ENTERED
Nov 27, 2012 LIME
LIMITATION OF GOODS RECEIVED FROM IB
Oct 24, 2012 LIMG
NOTIFICATION PROCESSED BY IB
Sep 15, 2012 GPNX
NEW REPRESENTATIVE AT IB RECEIVED
Sep 14, 2012 NREP
EXTENSION OF TIME TO OPPOSE RECEIVED
Sep 4, 2012 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 7, 2012 NPUB
PUBLISHED FOR OPPOSITION
Aug 7, 2012 PUBO
NEW REPRESENTATIVE AT IB RECEIVED
Jul 27, 2012 NREP
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jul 18, 2012 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jul 18, 2012 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 18, 2012 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jul 3, 2012 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 28, 2012 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 28, 2012 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 28, 2012 CRFA
ASSIGNED TO LIE
Jun 15, 2012 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 5, 2012 TROA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 30, 2012 TCCA
REFUSAL PROCESSED BY IB
Jan 9, 2012 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Dec 21, 2011 RFCS
REFUSAL PROCESSED BY MPU
Dec 21, 2011 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 20, 2011 RFCR
NON-FINAL ACTION WRITTEN
Dec 19, 2011 CNRT
APPLICATION FILING RECEIPT MAILED
Dec 13, 2011 MAFR
ASSIGNED TO EXAMINER
Dec 9, 2011 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 9, 2011 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 8, 2011 REPR